Hoffman, E.; Rahat, M.A.; Feld, J.; Elias, M.; Rosner, I.; Kaly, L.; Lavie, I.; Gazitt, T.; Zisman, D.
Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2019, 20, 4633.
https://doi.org/10.3390/ijms20184633
AMA Style
Hoffman E, Rahat MA, Feld J, Elias M, Rosner I, Kaly L, Lavie I, Gazitt T, Zisman D.
Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis. International Journal of Molecular Sciences. 2019; 20(18):4633.
https://doi.org/10.3390/ijms20184633
Chicago/Turabian Style
Hoffman, Elinoar, Michal A. Rahat, Joy Feld, Muna Elias, Itzhak Rosner, Lisa Kaly, Idit Lavie, Tal Gazitt, and Devy Zisman.
2019. "Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis" International Journal of Molecular Sciences 20, no. 18: 4633.
https://doi.org/10.3390/ijms20184633
APA Style
Hoffman, E., Rahat, M. A., Feld, J., Elias, M., Rosner, I., Kaly, L., Lavie, I., Gazitt, T., & Zisman, D.
(2019). Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis. International Journal of Molecular Sciences, 20(18), 4633.
https://doi.org/10.3390/ijms20184633